21 |
An investigation into the role of mitochondrial dysfunction in South African Parkinson’s disease patientsVan der Merwe, Celia 12 1900 (has links)
Thesis (MScMedSC)--Stellenbosch University, 2012. / Bibliography / ENGLISH ABSTRACT: Parkinson’s disease (PD) is a neurodegenerative movement disorder characterized by the loss of dopaminergic neurons in the substantia nigra of the midbrain. Although the aetiology of PD is still not fully understood, it is thought to involve a combination of environmental (such as exposure to pesticides and neurotoxins) and genetic factors. A number of PD-causing genes have been found including SNCA, LRRK2, EIF4G1 and VPS35 (for autosomal dominant forms of PD) and parkin, PINK1, DJ-1 and ATP13A2 (for autosomal recessive forms of PD – arPD). Mutations in the parkin gene are the predominant cause of arPD. Parkin plays a role in the ubiquitin-proteasomal system which degrades damaged and unwanted proteins in the cell and it is also thought to be involved in maintaining healthy mitochondria. Numerous studies have implicated mitochondrial function in the pathogenesis of PD. Therefore the aim of the present study was to investigate the role of mitochondrial dysfunction in PD patients with parkin-null mutations.
Four South African PD patients, each harbouring two parkin-null mutations, were recruited for this study. A muscle biopsy was performed for analysis of mitochondrial morphology using histology and transmission electron microscopy (TEM). Skin biopsies were taken, from which fibroblasts were cultured. These fibroblasts were used in i) mitochondrial morphological assessments using TEM, ii) mitochondrial network analysis, iii) functional studies via ROS measurement and iv) analysis of the proteome using a LTQ Orbitrap Velos mass spectrometer. In addition, RNA was isolated from peripheral blood samples for gene expression studies using the RT² Profiler PCR Array (SABiosciences, USA) and the RT² PCR Primer Assay (SABiosciences, USA). Heterozygous family members (carriers) and wild-type controls were also recruited for this study. Results from the histological and TEM analysis from the muscle biopsy observed subtle mitochondrial changes including the presence of type II fibres, atrophic fibres, the presence of lipids, and wrinkling of the sarcolemmal membrane. Enlarged mitochondria were also observed in one patient. TEM analysis on the patient’s fibroblasts observed an increase in the number of electron dense vacuoles, speculated to be autolysosomes. The mitochondrial network in two of the patients’ fibroblasts showed fragmented and dot-like networks which are indicative of damaged mitochondria. An increase in mitochondrial ROS levels was observed in three of the four patients. Expression studies found down-regulation of 14 genes from four of the five mitochondrial complexes and a total of 688 proteins were found only in the control and not in the patient fibroblasts. Some of these proteins are known to be part of the ‘mitochondrial dysfunction’ pathway.
Taken together, these results indicate that the absence of parkin results in a number of mitochondrial alterations. Based on these findings, a model of PD was proposed: It is speculated that when parkin is absent, electron transport chain complex genes are down-regulated. This results in impaired oxidative phosphorylation, causing an increase in the production of mitochondrial ROS and subsequent oxidative stress. Mitochondria are then damaged; resulting in the fragmentation of the mitochondrial network. The impaired mitochondria are thus tagged for degradation, causing the recruitment of autolysosomes which engulf the mitochondria via mitophagy. Ultimately, as the compensatory mechanisms fail, this triggers the consequential cascade of cellular apoptotic events.
This study has elucidated the effect of parkin on the mitochondria, and can act as a ‘stepping stone’ towards future development of therapeutic strategies and/or biochemical markers that will benefit not only patients with PD but also other neurodegenerative disorders. / AFRIKAANSE OPSOMMING: Parkinson se siekte (PS) is ‘n neurodegeneratiewe bewegings-afwyking gedefineer deur die verlies van dopaminergiese neurone in die substantia nigra van die midde brein. Alhoewel die spesifieke oorsprong van die afwyking nog nie ten volle begryp is nie, word bydraes van beide omgewings faktore (bv. blootstelling aan plaagdoders en neurotoksienes) asook genetiese faktore gespekuleer. Vanuit ‘n genetiese aspek is ‘n aantal gene al geassosieer met PS. Hierdie gene sluit in SNCA, LRRK2, EIF4G1 en VPS35 (vir outosomale dominante vorms van PS) en parkin, PINK1, DJ-1, en ATP13A2 (vir outosomale resessiewe vorms van PS - orPS). Mutasies in die parkin geen is aangedui as die hoof oorsaak van orPS. Parkin speel ‘n rol in die ubiquitine-proteasomale sisteem wat beskadige en ongewensde proteïne binne in die sel verwyder en is verdink om by te dra tot die instandhouding van gesonde mitokondria. Mitokondriese wanfunksionering is ook deur talle studies gewys as ‘n bydraende faktor in die patologie van PS. Die doel van die studie is om ondersoek in te stel tot die spesifieke rol wat mitokondriese wanfunsionering speel in PS pasiënte met parkin-nul mutasies.
Vier Suid-Afrikaanse PS-pasiënte, elk met twee parkin-nul mutasies, is gebruik vir die studie. Deur middel van spierbiopsies is monsters verkry vir mitokondriese morfologiese analises met behulp van histologiese en elektron-oordrag mikroskopie tegnieke (TEM). Vel biopsies is ook geneem en fibroblaste is gekweek vir die gebruik in: i) mitokondriese morfologiese assesering; ii) mitokondriese netwerk analiese; iii) funksionele studies waar vlakke van reaktiewe suurstof spesies (ROS) gemeet is; iv) proteoom analiese met behup van ‘n LTQ Orbitrap Velos massa spektrometer. RNA is ook geisoleer vanaf perifere bloedmonsters vir die gebruik in geen-uitdrukkings studies met behulp van ‘n RT² Profiler PCR Array en ‘n RT² Primer Assay. Selle vanaf famielie lede wat heterosigotiese draers is van die mutasie, asook normale (geen parkin mutasie) selle is gebruik as kontroles in die studie. TEM resultate vanaf die spier monsters het subtiele mitokondriese veranderinge getoon. Hierdie sluit in die teenwoordigheid van tipe II vesels, atrofiese vesels, teenwoordigheid van lipiedes, assook waarnemings van rimpeling van die sarcolemmal membraan. Vergrote mitokondrias is ook in een van die pasiënte opgelet. TEM resultate vanaf die fibroblaste het toename in die aantal elektron-digte vakuole vertoon, moontlik geidentifiseer as autolisosome. Gefragmenteerde en onderbreekte mitokondria netwerke is gelet tydens netwerk analiese van die fibroblaste, ‘n indikasie van beskadigde mitokondria. ‘n Toename in mitokondriese ROS vlakke is gevind in drie van die vier pasiënte. Af-regulering van 14 gene, geassosieerd met vier uit die vyf mitokondria komplekse, is verneem tydens die geen-uitdrukkings studie. Saam met dit is ‘n totaal van 688 proteïene geidentifiseer wat slegs teenwoordig is in die kontrole monsters en nie in die pasiënt monsters nie. Hierdie proteïene is almal uitgedruk en betrokke in die mitokondriese wanfunsionerings-weë.
Hierdie resultate dui dat die afwesigheid van parkin mitokondriese afwykings tot gevolg het wat kan lei tot die afsterwing van selle. Dit dra ook by tot die vorming van ‘n beter-verstaande siekte-model vir PS: Mutasies in parkin (wat lei tot die afwesigheid van parkin) kan dus moontlik lei tot die af-regulasie van gene geassosieerd met die elektron-vervoer ketting komplekse in die mitokondria. Dit lei tot gebrekkige oksidatiewe fosforilering en veroorsaak ‘n toename in die vorming van ROS, wat dan ‘n toename in oksidatiewe stres binne in die sel tot gevolg het. Uiteindelik lei dit dus tot die beskadiging van die mitokondria wat gepaard gaan met fragmentering van die mitokondriese netwerk. Beskadigde mitokondrias word geetiketeer vir afbraking. Hierdie etiketering aktiveer omringende autophagosome wat die beskadigde mitokondrias dan verwyder deur middel van ‘n verswelgende proses genaamd mitophagy. Dit veroorsaak die aktivering van ‘n aantal gekorreleerde sellulêre prosesse wat lei tot apoptose (afsterwing van die sel).
Hierdie studie dra by tot die verklaring van die spesifieke effek wat parkin mutasies het op die funksionering van die mitokondria. Resultate hier lê ook die grondslag vir toekomstige studies met die doel tot die ontwikkeling van terapeutiese strategeë en biochemiese merkers wat kan bydrae tot die genesing van beide pasiënte met PS, asook pasiënte met ander neurodegeneratiewe afwykings.
|
22 |
Efeitos crônicos da angiotensina II sobre a atividade e expressão da isoforma 3 do trocador Na+/H+. / Chronic effects of angiotensin II on the isoform 3 of Na+/H+ exchanger (NHE3).Leite, Gabriella Duarte Queiroz 23 March 2011 (has links)
NHE3 reabsorve a maior parte de Na+ em túbulos proximais e é agudamente modulado por Ang II de forma bimodal. O objetivo deste trabalho foi avaliar os efeitos crônicos da Ang II sobre a atividade, expressão e atividade promotora de NHE3. A atividade de NHE3 foi avaliada na presença de veículo, inibidor de NHE1, 2 e 3 e H+ ATPase. Houve redução da recuperação do pHi na presença do inibidor de NHE3. Células foram expostas por 24h a Ang II de 10-7M a 10-12 M e houve aumento de atividade com Ang II 10-11 M. Houve aumento na expressão de NHE3 e no seu RNAm. Actinomicina D não mostrou diferença entre os tempos de ½ vida do RNAm. Transfecções transitórias de fragmentos do promotor de NHE3 de rato mostraram que a atividade do fragmento -65/+31 aumentou na presença de Ang II. Mutações em sítios para a ligação de Sp1/Egr-1 e AP2 mostraram que o sítio Sp1/Egr-1 é fundamental para esse efeito. As vias que envolvem o citocromo P450, PI3K, PKA e MAPK são ativadas, porém, as vias da PLC e JAK/STAT não. Losartan aboliu os efeitos observados. Conclui-se que a exposição crônica à baixa concentração de Ang II promoveu aumento na atividade, expressão, nível de RNAm e atividade promotora do gene NHE3 via AT1R. O sítio de ligação para os fatores de transcrição Sp1/Egr-1 está envolvido nessa resposta. / NHE3 is the major responsible for the sodium reabsorption in proximal tubules and it is Ang II acutely modulated in a bimodal fashion. The aim of this study was to evaluate the chronic effects of Ang II on NHE3 activity, transcription and expression. The NHE3 activity was evaluated in the presence of vehicle, NHE1, 2 and 3 and H+ ATPase inhibitors. Presence of NHE3 inhibitor reduced the rate of pHi recovery. Cells were treated with Ang II 10-7M to 10-12 M for 24h and Ang II 10-11 M increased the pHi recovery rate. NHE3 protein and mRNA were increased in Ang II presence. NHE3 mRNA ½ life in Actinomycin D incubated cells was not affected by Ang II treatment. Transient transfections of fragments of rat NHE3 promoter showed that the activity of -65/+31 was increased in Ang II presence. Mutation at Sp1/Egr-1 and AP2 sites in the -60/+31 fragment showed that Sp1/Egr-1 integrity is required. Cytochrome P450, PI3K, PKA and MAPK signaling pathways are related with this effect, while PLC and JAK/STAT are not. Losartan abolished the observed effects. In conclusion, chronic treatment with low concentration of Ang II resulted in increase of NHE3 activity, protein expression, mRNA levels and promoter activity of NHE3 gene through AT1R. Sp1/Egr-1 site seems to be involved in this effect.
|
23 |
Mapeamento genético e caracterização fenotípica do mutante anêmico induzido por Ethyl-nitroso-urea. / Genetic mapping and phenotypic characterization of an anemic mutant by ethylnitrosourea.Cruz, Carolina Cavalcante da 24 September 2009 (has links)
A mutagênese química utilizando o agente mutagênico N-ethyl-N-nitrosourea (ENU) seguida da observação do fenótipo deu origem a um mutante Anêmico. O tipo de herança é autossômica dominante, com morte intra útero dos mutantes homozigotos. O mapeamento genético foi feito utilizando-se marcadores microssatélites, sendo selecionados marcadores polimórficos entre as linhagens BALB/c e C57BL/6 envolvidas no mapeamento. Estabeleceu-se um painel de microssatélites distribuídos por todo o genoma do camundongo, que permitisse a localização do cromossomo portador da mutação. O gene mutante foi localizado no cromossomo 7 entre os marcadores D7Mit301 e D7Mit131 delimitando um intervalo entre 46,5cM e 51cM de 4,5cM. Através das análises fenotípicas do mutante Anêmico e estudo dos genes candidatos neste intervalo, foi selecionado o gene Hbb responsável pela síntese das globinas b-major e b-minor , sendo o gene que mais se identifica com as características do mutante, localizado a 50cM. A deficiência deste gene leva a uma das mais severas anemias humana, a b-Talassemia major. / Chemical mutagenesis, using the mutagenic agent N-ethyl-N-nitrosourea (ENU), and followed by observation of the phenotype, originated in an Anaemic mutant. The inheritance-type is dominant auto-somic, with intra-uterus death of the homozygotic mutants. Genetic mapping was undertaken by means of micro-satellite markers, polymorphic markers being selected from among the BALB/c and C57BL/6 lineages involved in the mapping itself. A panel was established of the micro-satellites distributed throughout the whole mouse genome, thereby permitting localization of the mutation bearing chromosome. The mutant gene was located in chromosome 7 between markers D7Mit301 and D7Mit131, these delimiting an interval between 46,5cM and 51cM of 4,5cM. Selection of the Hbb gene responsible for synthesis of the b-major and b-minor globins came about through phenotypic analysis of the Anaemic mutant and a study of candidate genes within this interval, the selected gene being that which was most identified with the mutants characteristics and located at 50cM. A deficiency in this gene leads to one of the most severe forms of human anaemia, b-Talhassemia major.
|
24 |
ANÁLISE MOLECULAR DO GENE RECEPTOR DE ANDRÓGENO EM PACIENTES E FAMILIARES COM SÍNDROME DA INSENSIBILIDADE AOS ANDRÓGENOS / MOLECULAR ANALYSIS OF ANDROGEN RECEPTOR GENE IN PATIENTS AND RELATIVES WITH ANDROGEN INSENSITIVITY SYNDROMEAndrade, Marcelo Souza de 25 April 2012 (has links)
Made available in DSpace on 2016-08-16T18:18:42Z (GMT). No. of bitstreams: 1
Tese MARCELO SOUZA DE ANDRADE.pdf: 1768433 bytes, checksum: 8051d8f14c6a38ec8166fcb2e817b674 (MD5)
Previous issue date: 2012-04-25 / FUNDAÇÃO DE AMPARO À PESQUISA E AO DESENVOLVIMENTO CIENTIFICO E TECNOLÓGICO DO MARANHÃO / Introduction. The androgen insensitivity syndrome (AIS) is a rare disease (1:20,000 to 1:64.000)-linked X chromosome, which generates a disorder of sexual differentiation of the male fetus (XY) with a spectrum of phenotypes ranging from females complete (CAIS) to a male phenotype with discrete signs of androgen insensitivity. An increasing number of mutations have been cataloged and nearly 500 mutations have been related to CAIS and 1000 to the androgen receptor gene. The AR gene is located on Xq11-12, with eight exons, about 919 amino acids. Objective. To characterize the mutations in the AR gene families in the region of the "Bico do Papagaio" in the southwestern state of Maranhao. Methodology. We used molecular biology techniques such as DNA extraction, PCR, electrophoresis, purification of PCR products and sequencing. In addition, we analyzed the clinical and hormonal characteristics of 14 patients and their families. Results. In one family (with two twin affected), we found the mutation R753X and the third molecular diagnosis of CAIS in twins described in the World. In another family, with 12 patients, was identified a new mutation in exon 8, as described P893A, protein AR. Conclusion. This work enabled the application of molecular techniques for the accurate diagnosis of AIS, genetic counseling for relatives of affected patients, and contribute to the formation of more qualified human resources, aiming at the development of biotechnology in the state of Maranhão. / Introdução. A Síndrome de Insensibilidade Androgênica (AIS) é uma doença rara (1:20.000 a 1:64.000), de transmissão ligada ao cromossomo X, que gera um distúrbio da diferenciação sexual do feto masculino (XY) com um espectro de fenótipo que varia desde o feminino completo (CAIS) até um fenótipo masculino com discretos sinais de insensibilidade androgênica. Um número crescente de mutações tem sido catalogadas e quase 500 mutações já foram relacionadas à CAIS e cerca de 1000 ao gene do receptor androgênico. O gene AR localiza-se em Xq11-12, com 8 exons, com cerca de 919 aminoácidos. Objetivo. Caracterizar as mutações no gene AR em famílias da região do Bico do Papagaio , no sudoeste do Estado do Maranhão. Metodologia. Foram utilizadas técnicas de biologia molecular como extração de DNA, PCR, Eletroforese, Purificação de produtos de PCR e Sequenciamento automático. Além disso, foram analisados o quadro clínico e hormonal de 14 pacientes e de seus familiares. Resultados. Em uma das famílias (com duas gêmeas afetadas), foi encontrada a mutação R753X, sendo o terceiro diagnóstico molecular de CAIS em gêmeas descrito no Mundo. Em outra família, com 12 pacientes, foi a identificada uma mutação nova no exon 8, descrita como P893A, na proteína AR. Conclusão. Este trabalho possibilitou a aplicação de técnicas moleculares para o diagnóstico preciso de AIS, aconselhamento genético aos familiares das pacientes afetadas, além de contribuir para a formação de recursos humanos mais qualificados, visando o desenvolvimento da biotecnologia no Estado do Maranhão.
|
25 |
Efeitos crônicos da angiotensina II sobre a atividade e expressão da isoforma 3 do trocador Na+/H+. / Chronic effects of angiotensin II on the isoform 3 of Na+/H+ exchanger (NHE3).Gabriella Duarte Queiroz Leite 23 March 2011 (has links)
NHE3 reabsorve a maior parte de Na+ em túbulos proximais e é agudamente modulado por Ang II de forma bimodal. O objetivo deste trabalho foi avaliar os efeitos crônicos da Ang II sobre a atividade, expressão e atividade promotora de NHE3. A atividade de NHE3 foi avaliada na presença de veículo, inibidor de NHE1, 2 e 3 e H+ ATPase. Houve redução da recuperação do pHi na presença do inibidor de NHE3. Células foram expostas por 24h a Ang II de 10-7M a 10-12 M e houve aumento de atividade com Ang II 10-11 M. Houve aumento na expressão de NHE3 e no seu RNAm. Actinomicina D não mostrou diferença entre os tempos de ½ vida do RNAm. Transfecções transitórias de fragmentos do promotor de NHE3 de rato mostraram que a atividade do fragmento -65/+31 aumentou na presença de Ang II. Mutações em sítios para a ligação de Sp1/Egr-1 e AP2 mostraram que o sítio Sp1/Egr-1 é fundamental para esse efeito. As vias que envolvem o citocromo P450, PI3K, PKA e MAPK são ativadas, porém, as vias da PLC e JAK/STAT não. Losartan aboliu os efeitos observados. Conclui-se que a exposição crônica à baixa concentração de Ang II promoveu aumento na atividade, expressão, nível de RNAm e atividade promotora do gene NHE3 via AT1R. O sítio de ligação para os fatores de transcrição Sp1/Egr-1 está envolvido nessa resposta. / NHE3 is the major responsible for the sodium reabsorption in proximal tubules and it is Ang II acutely modulated in a bimodal fashion. The aim of this study was to evaluate the chronic effects of Ang II on NHE3 activity, transcription and expression. The NHE3 activity was evaluated in the presence of vehicle, NHE1, 2 and 3 and H+ ATPase inhibitors. Presence of NHE3 inhibitor reduced the rate of pHi recovery. Cells were treated with Ang II 10-7M to 10-12 M for 24h and Ang II 10-11 M increased the pHi recovery rate. NHE3 protein and mRNA were increased in Ang II presence. NHE3 mRNA ½ life in Actinomycin D incubated cells was not affected by Ang II treatment. Transient transfections of fragments of rat NHE3 promoter showed that the activity of -65/+31 was increased in Ang II presence. Mutation at Sp1/Egr-1 and AP2 sites in the -60/+31 fragment showed that Sp1/Egr-1 integrity is required. Cytochrome P450, PI3K, PKA and MAPK signaling pathways are related with this effect, while PLC and JAK/STAT are not. Losartan abolished the observed effects. In conclusion, chronic treatment with low concentration of Ang II resulted in increase of NHE3 activity, protein expression, mRNA levels and promoter activity of NHE3 gene through AT1R. Sp1/Egr-1 site seems to be involved in this effect.
|
26 |
Identificação de genes de Burkholderia sp. associados ao controle biológico de Pectobacterium carotovora. / Identification of genes of Burkhoderia sp. associated with biological control of Pectobacterium carotovora.Emy Tiyo Mano 28 February 2011 (has links)
A bacteria Pectobacterium carotovora causa danos a diferentes hospedeiros por meio da produção de enzimas pectinolíticas que degradam o pectato de cálcio da lamela media próximo a parede celular, causando extravasamento do conteúdo celular, sintomas da podridão mole. Bactérias do gênero Burkholderia tem se mostrado capazes em controlar a podridão mole em orquídeas, no entanto, os aspectos moleculares envolvidos neste controle ainda não foram estudados. Neste trabalho, foram avaliados 602 transformantes quanto a sua habilidade em inibir os sintomas da podridão mole, onde foram observados 16 mutantes defectivos no controle da doença. Destes, foram identificados sete diferentes genes inativados pelo transposon Tn5, e estes genes podem estar envolvidos em processos de síntese de aleloquímicos, competição por nutrientes, adaptação a condições ambientais, e na interação com o hospedeiro e/ou entre microrganismos. No entanto, o envolvimento destes genes na perda da capacidade em controlar a podridão mole deve ser melhor estudado. / The bacterium Pectobacterium carotovora cause damage to different hosts and by production of pectic enzymes that degrade calcium pectate of the middle lamella near of the cell wall, causing overflow of cell content and consequently the soft rot. Burkholderia genus has proven able to control the soft rot in Orchids, however, the molecular aspects involved in the control have not been studied. In this work, 602 transformants were characterized for their ability to inhibit soft rot caused by P. carotovora. We identified 16 mutants showing shifts in inhibition pattern or lost of the ablitity to inhibit soft rot symptoms. Among these mutants, we identified 7 genes related to disease inhibition,and this genes may be involved in process of allelochemicals synthesis, competition for nutrients, adapting to environmental conditions, and interaction between the host and microorganisms. However, the involvement of these genes in loss of ability to control the soft rot disease is being further studied in details.
|
27 |
Estimating Likelihood of Having a BRCA Gene Mutation Based on Family History of Cancers and Recommending Optimized Cancer Preventive ActionsAbdollahian, Mehrnaz 12 November 2015 (has links)
BRCA1 and BRCA2 are gene mutations that drastically increase chances of developing breast and ovarian cancers, up to 20-fold, for women. A genetic blood test is used to detect BRCA mutations. Though these mutations occur in one of every 400 in the general population (excluding Ashkenazi Jewish ethnicity), they are present in most cases of hereditary breast and ovarian cancer patients. Hence, it is common practice for the physicians to require genetic testing for those that fit the rules as recommended by the National Cancer Comprehensive Network. However, data from the Myriad Laboratory, the only provider of the test until 2013, show that over 70 percent of those tested are negative for BRCA mutations [1]. As there are significant costs and psychological trauma associated with having to go through the test, there is a need for more comprehensive rules for determining who should be tested. Once the presence of BRCA is identified via testing, the next challenge for both mutation carriers and their physicians is to select the most appropriate types and timing of intervention actions. Organizations such as the American Cancer Society suggest drastic intervention actions such as prophylactic surgeries and intense breast screenings. These actions vary significantly in their cost, cancer incidence prevention ability, and can have major side effects potentially resulting in reproduction inability or death. Effectiveness of these intervention actions is also age dependent.
In this dissertation, both an analytical and an optimization framework are presented. The analytical framework uses supervised machine learning models on extended family history of cancers, and personal and medical information from a recent nationwide survey study of women who have been referred for genetic testing for the presence of a BRCA mutation. This framework provides the potential mutation carriers as well as their physician with an estimate of the likelihood of having the mutations. The optimization framework uses a Markov decision process (MDP) model to find cost-optimal and/or quality-adjusted life years (QALYs) optimal intervention strategies for those tested positive for a BRCA mutation. This framework uses a dynamic approach to address this problem. The decisions are made more robust by considering the variation in estimates of the transition probabilities by using a robust version of the MDP model.
This research study delivers an innovative decision support tool that enables physicians and genetic consultants predict the population at high risk of breast and ovarian cancers more accurately. For those identified with presence of the BRCA mutation, the decision support tool offers effective intervention strategies considering either minimizing cost or maximizing QALYs to prevent incidence of cancers.
|
28 |
Mapeamento genético e caracterização fenotípica do mutante anêmico induzido por Ethyl-nitroso-urea. / Genetic mapping and phenotypic characterization of an anemic mutant by ethylnitrosourea.Carolina Cavalcante da Cruz 24 September 2009 (has links)
A mutagênese química utilizando o agente mutagênico N-ethyl-N-nitrosourea (ENU) seguida da observação do fenótipo deu origem a um mutante Anêmico. O tipo de herança é autossômica dominante, com morte intra útero dos mutantes homozigotos. O mapeamento genético foi feito utilizando-se marcadores microssatélites, sendo selecionados marcadores polimórficos entre as linhagens BALB/c e C57BL/6 envolvidas no mapeamento. Estabeleceu-se um painel de microssatélites distribuídos por todo o genoma do camundongo, que permitisse a localização do cromossomo portador da mutação. O gene mutante foi localizado no cromossomo 7 entre os marcadores D7Mit301 e D7Mit131 delimitando um intervalo entre 46,5cM e 51cM de 4,5cM. Através das análises fenotípicas do mutante Anêmico e estudo dos genes candidatos neste intervalo, foi selecionado o gene Hbb responsável pela síntese das globinas b-major e b-minor , sendo o gene que mais se identifica com as características do mutante, localizado a 50cM. A deficiência deste gene leva a uma das mais severas anemias humana, a b-Talassemia major. / Chemical mutagenesis, using the mutagenic agent N-ethyl-N-nitrosourea (ENU), and followed by observation of the phenotype, originated in an Anaemic mutant. The inheritance-type is dominant auto-somic, with intra-uterus death of the homozygotic mutants. Genetic mapping was undertaken by means of micro-satellite markers, polymorphic markers being selected from among the BALB/c and C57BL/6 lineages involved in the mapping itself. A panel was established of the micro-satellites distributed throughout the whole mouse genome, thereby permitting localization of the mutation bearing chromosome. The mutant gene was located in chromosome 7 between markers D7Mit301 and D7Mit131, these delimiting an interval between 46,5cM and 51cM of 4,5cM. Selection of the Hbb gene responsible for synthesis of the b-major and b-minor globins came about through phenotypic analysis of the Anaemic mutant and a study of candidate genes within this interval, the selected gene being that which was most identified with the mutants characteristics and located at 50cM. A deficiency in this gene leads to one of the most severe forms of human anaemia, b-Talhassemia major.
|
29 |
Identificação de genes de Burkholderia sp. associados ao controle biológico de Pectobacterium carotovora. / Identification of genes of Burkhoderia sp. associated with biological control of Pectobacterium carotovora.Mano, Emy Tiyo 28 February 2011 (has links)
A bacteria Pectobacterium carotovora causa danos a diferentes hospedeiros por meio da produção de enzimas pectinolíticas que degradam o pectato de cálcio da lamela media próximo a parede celular, causando extravasamento do conteúdo celular, sintomas da podridão mole. Bactérias do gênero Burkholderia tem se mostrado capazes em controlar a podridão mole em orquídeas, no entanto, os aspectos moleculares envolvidos neste controle ainda não foram estudados. Neste trabalho, foram avaliados 602 transformantes quanto a sua habilidade em inibir os sintomas da podridão mole, onde foram observados 16 mutantes defectivos no controle da doença. Destes, foram identificados sete diferentes genes inativados pelo transposon Tn5, e estes genes podem estar envolvidos em processos de síntese de aleloquímicos, competição por nutrientes, adaptação a condições ambientais, e na interação com o hospedeiro e/ou entre microrganismos. No entanto, o envolvimento destes genes na perda da capacidade em controlar a podridão mole deve ser melhor estudado. / The bacterium Pectobacterium carotovora cause damage to different hosts and by production of pectic enzymes that degrade calcium pectate of the middle lamella near of the cell wall, causing overflow of cell content and consequently the soft rot. Burkholderia genus has proven able to control the soft rot in Orchids, however, the molecular aspects involved in the control have not been studied. In this work, 602 transformants were characterized for their ability to inhibit soft rot caused by P. carotovora. We identified 16 mutants showing shifts in inhibition pattern or lost of the ablitity to inhibit soft rot symptoms. Among these mutants, we identified 7 genes related to disease inhibition,and this genes may be involved in process of allelochemicals synthesis, competition for nutrients, adapting to environmental conditions, and interaction between the host and microorganisms. However, the involvement of these genes in loss of ability to control the soft rot disease is being further studied in details.
|
30 |
Albright’s Hereditary Osteodystrophy Associated with Cerebellar Pilocytic Astrocytoma: Coincidence or Genetic Relationship?Sobottka, Stephan B., Hübner, Angela, Haase, Markus, Ahrens, Wiebke, Rupprecht, Edgar, Schackert, Hans K., Schackert, Gabriele January 2001 (has links)
Albright’s hereditary osteodystrophy (AHO) is a rare inherited disease characterized by skeletal abnormalities, short stature, and, in some cases, resistance to parathyroid hormone, resulting in pseudohypoparathyroidism (PHP). Heterozygous inactivating mutations of the GNAS1 gene are responsible for reduced activity of the alpha subunit of the Gs protein (GSα), a protein that mediates hormone signal transduction across cell membranes. Gsα is also known to have oncogenic potentials, leading to the development of human pituitary tumors and Leydig cell tumors. Here, we report the 1st case, a 3.5-year-old girl, with classic AHO phenotype and PHP type 1A associated with a cerebellar pilocytic astrocytoma. Coincidence or genetic relationships of both diseases are discussed according to molecular findings and current literature. / Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
|
Page generated in 0.0788 seconds